Dr. Joanna Paolilli, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30 Daniel Webster Hwy, Suite 11, Merrimack, NH 03054 Phone: 603-883-3365 |
Dr. Jack Faraci, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 30 Daniel Webster Hwy, Suite 11, Merrimack, NH 03054 Phone: 603-883-3365 |
Bettina M Costello, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7 Executive Park Drive, Home Health & Hospice Care, Merrimack, NH 03054 Phone: 603-882-2941 Fax: 603-429-1844 |
Peggy Jean Bleezarde, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 297 Daniel Webster Hwy Ste 4, Merrimack, NH 03054 Phone: 603-883-3550 |
Dr. Jeffrey Nathan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 30 Daniel Webster Hwy, Suite 11, Merrimack, NH 03054 Phone: 603-883-3365 |
News Archive
A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.
An eating disorders research team led by Stephen Wonderlich, a Director of Clinical Research at the Neuropsychiatric Research Institute (NRI), has developed a successful bulimia nervosa therapy that can provide patients an alternative for treating this debilitating disorder.
First lady Michelle Obama on Tuesday asked nurses to help spread the word of the benefits of the health law. More than 1,000 nurses joined the first lady on the call, in which she briefly outlined some of the law's protections and benefits.
Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center will present findings from a study that found the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer.
The health law is signed - though some changes are still pending - but the fight continues, The Washington Post reports. "Interest groups that spent the past year fighting over President Obama's health-care overhaul are quickly transforming themselves for battle in a new arena, working to sway the law to their benefit while helping the lawmakers who supported them during the bruising legislative debate. For instance, labor unions and industry lobbying groups will attempt to influence regulation writing. Progressives and unions will spend millions to sell the still-controversial plan to voters. Conservatives who opposed it are now retargeting their ire to vulnerable Democratic lawmakers who supported the legislation
› Verified 3 days ago